4 completed, 3 recruiting, 2 enrolling by invitation, 1 not yet recruiting. 4 Phase 2, 3 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 2 |
| Not applicable | 3 | Completed 1, Enrolling by invitation 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Eczema Atopic Dermatitis: new trials by email Literature Review of Eczema Atopic Dermatitis trials Research Report on Eczema Atopic Dermatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis Camoteskimab, Placebo - Atopic Dermatitis, Atopic | Phase 2 | Recruiting | Apollo Therapeutics Ltd | 280 | 2026-05-28 | 2026-08-28 |
| A Study on the Efficacy of 2% Cholesterol Cream in Atopic Dermatitis Topical 2% cholesterol cream, Placebo Vehicle Cream - Atopic Dermatitis (AD), Cholesterol | Not applicable | Enrolling by invitation | Institute of Dermatology, Thailand | 30 | 2026-04-01 | 2026-05-14 |
| Preventive Effect of a Dietary Supplement With Two Probiotic Limosilactobacillus Reuteri Strains on Excessive Crying and Colic in Healthy Newborns. Two probiotic Limosilactobacillus reuteri strains, Placebo - Colic, Healthy Infants | Not applicable | Recruiting | Universitair Ziekenhuis Brussel | 768 | 2026-01-31 | 2026-02-19 |
| Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective No Intervention: Observational Cohort - Atopic Dermatitis, Eczema Atopic Dermatitis | Not yet recruiting | PeriPharm | 100 | 2026-01-01 | 2026-01-23 | |
| A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) GX-03, Vehicle - Eczema Atopic Dermatitis, Eczema | Phase 2 / Phase 3 | Recruiting | Turn Therapeutics | 190 | 2025-07-11 | 2026-09-04 |
| Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis EVO301, Placebo - Atopic Dermatitis (AD), Eczema | Phase 2 | Completed | Evommune, Inc. | 71 | 2025-02-13 | 2025-12-04 |
| The Skin Microbiota in Skin Disease and Eczema Skin Disease, Eczema | Enrolling by invitation | Region Skane | 100 | 2025-01-20 | 2026-05-04 | |
| Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists AI-based medical device for aided diagnosis in Dermatology - Pustular Psoriasis (PP), Generalized Pustular Psoriasis (GPP) | Completed | AI Labs Group S.L | 15 | 2024-06-01 | 2026-02-24 | |
| A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis Camoteskimab, Placebo - Atopic Dermatitis, Atopic | Phase 2 | Completed | Apollo Therapeutics Ltd | 62 | 2024-05-01 | 2025-09-18 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease There is no intervention in this study - Gut Microbiome, Gastrointestinal Microbiome | Suspended | ProgenaBiome | 1000 | 2019-07-11 | 2026-09-21 | |
| Short-term Topical Application to Prevent Atopic Dermatitis Skin barrier protection in the first 2 months of life - Eczema Atopic Dermatitis, Eczema | Not applicable | Completed | University College Cork | 321 | 2019-04-16 | 2022-06-22 |
Eczema (8) · Dermatitis, Atopic (7) · Skin Diseases (4) · Acne Vulgaris (2) · Dermatitis (2) · Psoriasis (2) · Acne Conglobata (1) · Acute Generalized Exanthematous Pustulosis (1) · Alzheimer Disease (1) · Amyotrophic Lateral Sclerosis (1) · Anxiety Disorders (1) · Arthritis, Rheumatoid (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1) · Bipolar Disorder (1)
Skin Diseases, Eczematous (10) · Skin and Connective Tissue Diseases (10) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Immune System Diseases (9) · Dermatitis (8) · Genetic Diseases, Inborn (8) · Hypersensitivity (8) · Skin Diseases, Genetic (8) · Hypersensitivity, Immediate (7) · Skin Diseases (6) · Acneiform Eruptions (2) · Autoimmune Diseases (2) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Behavior (2)
Apollo Therapeutics Ltd (2) · AI Labs Group S.L (1) · Evommune, Inc. (1) · Institute of Dermatology, Thailand (1) · PeriPharm (1) · ProgenaBiome (1) · Region Skane (1) · Turn Therapeutics (1) · Universitair Ziekenhuis Brussel (1) · University College Cork (1)
United States (4) · Canada (2) · Spain (2) · Australia (1) · Belgium (1) · Bulgaria (1) · Czechia (1) · Germany (1) · Hungary (1) · Ireland (1) · New Zealand (1) · Poland (1) · Sweden (1) · Thailand (1)
Antonio Martorell, PhD (1) · Chavalit Supsrisunjai, MD, PhD (1) · Koen Huysentruyt, Pediatric Gastroenterologist (1) · Sabine Hazan, MD (1)